AFP and neoplasm: In addition, Child-Pugh class, tumor size, EHS and/or RNI, AFP level ≥400 ng/mL, PIVKA level ≥1,000 AU/L, and the cumulative dose of sorafenib (transformed by natural logarithm) significantly predicted PFS in univariate analysis (all P < 0.05; Table 2).